Aluminum and Alzheimer's disease: A new look

Journal of Alzheimer's Disease

Volumn 10, Issue 2-3, 2006, Pages 179-201

  Miu, Andrei C ^a,b   Benga, Oana ^a  

^a BABE BOLYAI UNIVERSITY   (Romania)

^b NONE   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN; DRINKING WATER;

ALUMINUM OVERLOAD; ALZHEIMER DISEASE; ANALYTIC METHOD; BRAIN NERVE CELL; CELL ULTRASTRUCTURE; CREUTZFELDT JAKOB DISEASE; DIALYSIS ENCEPHALOPATHY; DISSOCIATION; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; HUMAN; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PAIRED HELICAL FILAMENT; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE; WATER CONTAMINATION;

EID: 33751086783     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-102-306     Document Type: Review

References (234)

1. M.G. Abubakar, A. Taylor and G.A. Ferns, Regional accumulation of aluminium in the rat brain is affected by dietary vitamin E, J Trace Elem Med Biol 18(1) (2004), 53-59.
2. A.C. Alfrey, Systemic Toxicity of Aluminum in Man. Neurobiology of Aging, (Vol. 7), Issue 6, November-December 1986, 543-545.
3. A.C. Alfrey, Aluminum metabolism, Kidney Int Suppl 18 (Feb. 1986), S8-S11.
4. A.C. Alfrey, Dialysis encephalopathy syndrome, Annu Rev Med 29 (1978), 93-98.
5. A.C. Alfrey, G.R. LeGendre and W.D. Kaehny, The dialysis encephalopathy syndrome. Possible aluminum intoxication, N Engl J Med 294(4) (22 Jan. 1976), 184-188.
6. A.C. Alfrey, J.M. Mishell, J. Burks, S.R. Contiguglia, H. Rudolph, E. Lewin and J.H. Holmes, Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis, Trans Am Soc Artif Intern Organs 18(0) (1972), 257-261, 266-267.
7. P. Altmann, J. Cunningham, U. Dhanesha, M. Ballard, J. Thompson and F. Marsh, Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident, BMJ 319 (1999), 807-811.
8. R. Anane and E.E. Creppy, Effects of Aluminium Chloride on Mouse Hippocampal Neurons in Culture, Toxicology Lett Suppl, 1/78, 1995, 1-88.
9. E.1 Andrasim, E.1 Farkas, Z.2 Molnar and E. Bertalan, Analysis of Aluminum in the Human Brain, Microchemical Journal 54(3) (October 1996), 210-217(8).
10. E. Andrasi, N. Pali, Z. Molnar and S. Kosel, Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients, J Alzheimers Dis 7(4) (Aug. 2005), 273-284.
11. D.A. Aremu and S. Meshitsuka, Some aspects of astroglial functions and aluminum implications for neurodegeneration, Brain Res Brain Res Rev 52(1) (30 Aug. 2006), 193-200.
12. W. Asch and D. Asch, The Silicates in Chemistry and Commerce, Constable et co. Ltd., London, 1918.
13. K.H. Ashe, Learning and memory in transgenic mice modeling Alzheimer's disease, Learn Mem 8(6) (Nov-Dec. 2001), 301-308.
14. K.H. Ashe, Molecular basis of memory loss in the Tg2576 mouse model of Alzheimer's disease, J Alzheimers Dis 9(3 Suppl) (Aug. 2006), 123-126.
15. H. Atamna, Heme, iron, and the mitochondrial decay of ageing, Ageing Res Rev 3(3) (Jul. 2004), 303-318.
16. H. Atamna, Heme Binding to Amyloid-β Peptide: A Mechanism for Neuroprotection from Alzheimer's Disease, J Alzheimer's Dis (this issue).
17. H. Atamna, D.W. Killilea, A.N. Killilea and B.N. Ames, Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging, Proc Natl Acad Sci USA 99(23) (12 Nov. 2002), 14807-14812.
18. H. Atamna and K. Boyle, Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease, Proc Natl Acad Sci USA 103(9) (28 Feb. 2006), 3381-3386.
19. D. Beauchemin and R. Kisilevsky, A method based on ICPMS for the analysis of Alzheimer's amyloid plaques, Anal Chem 70(5) (1 Mar. 1998), 1026-1029.
20. G. Becking and N.D. Priest, Is aluminium in drinking water a neurotoxic risk to humans? in: Managing Health in the Aluminium Industry, N.D. Priest and T.V. O'Donnell, eds, Middlesex University Press, London, pp. 300-307.
21. M. Benuck, K. Iqbal, H.M. Wisniewski and A. Lajtha, Proteolytic activity in brains of rabbits treated with aluminum, Neurochem Res 10(6) (Jun. 1985), 729-736.
22. Bharathi, K.S. Jagannatha Rao and R. Stein, First evidence on induced topological changes in supercoiled DNA by an aluminium D-aspartate complex, J Biol Inorg Chem 8(8) (Nov. 2003), 823-830.
23. A. Bizzi, R.C. Crane, L. Autilio-Gambetti and P. Gambetti, Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport, J Neurosci 4(3) (Mar. 1984), 722-731.
24. E. Bjertness, J.M. Candy, A. Torvik, P. Ince, F. McArthur, G.A. Taylor, S.W. Johansen, J. Alexander, J.K. Gronnesby, L.S. Bakketeig and J.A. Edwardson, Content of brain aluminum is not elevated in Alzheimer disease, Alzheimer Dis Assoc Disord 10(3) (Fall 1996), 171-174.
25. S.C. Bondy and A. Truong, Potentiation of beta-folding of beta-amyloid peptide 25-35 by aluminum salts, Neurosci Lett 267(1) (21 May 1999), 25-28.
26. C. Bouras, P. Giannakopoulos, P.F. Good, A. Hsu, P.R. Hof and D.P. Perl, A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease, Eur Neurol 38(1) (1997), 53-58.
27. P.L. Bryant, W.J. Lukiw, Z. Gan, R.W. Hall and L.G. Butler, High-field 19.6T 27Al solid-state MAS NMR of in vitro aluminated brain tissue, J Magn Reson 170(2) (Oct. 2004), 257-262.
28. O. Bugiani and B. Ghetti, Progressing encephalomyelopathy with muscular atrophy, induced by aluminum powder, Neurobiol Aging 3(3) (1982 Fall), 209-222.
29. A. Campbell, M.A. Smith, L.M. Sayre, S.C. Bondy and G. Perry, Mechanisms by which metals promote events connected to neurodegenerative diseases, Brain Res Bull 55(2) (15 May 2001), 125-132.
30. A. Campbell, The potential role of aluminium in Alzheimer's disease, Nephrol Dial Transplant 17(Suppl 2) (2002), 17-20.
31. A. Campbell, D. Hamai and S.C. Bondy, Differential toxicity of aluminum salts in human cell lines of neural origin: implications for neurodegeneration, Neurotoxicology 22(1) (Feb. 2001), 63-71.
32. J.J. Canales, R. Corbalan, C. Montoliu, M. Llansola, P. Monfort, S. Erceg, M. Hernandez-Viadel and V. Felipo, Aluminium impairs the glutamate-nitric oxide-cGMP pathway in cultured neurons and in rat brain in vivo: molecular mechanisms and implications for neuropathology, J Inorg Biochem 87(1-2) (Nov. 2001), 63-69.
33. J.M. Candy, A.E. Oakley, J. Klinowski, T.A. Carpenter, R.H. Perry, J.R. Atack, E.K. Perry, G. Blessed, A. Fairbairn and J.A. Edwardson, Aluminosilicates and senile plaque formation in Alzheimer's disease, Lancet 1(8477) (15 Feb. 1986), 354-357.
34. J.M. Candy, F.K. McArthur, A.E. Oakley, G.A. Taylor, C.P. Chen, S.A. Mountfort, J.E. Thompson, P.R. Chalker, H.E. Bishop, K. Beyreuther, G. Perry, M.K. Ward, C.N. Martyn and J.A. Edwardson, Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure, J Neurol Sci 107(2) (Feb. 1992), 210-218.
35. R.J. Castellani, H.G. Lee, X. Zhu, A. Nunomura, G. Perry and M.A. Smith, Neuropathology of Alzheimer disease: pathognomonic but not pathogenic, Acta Neuropathol (Berl) 111(6) (Jun. 2006), 503-509.
36. A.H. Chafi, J.J. Hauw, G. Rancurel, J.P. Berry and C. Galle, Absence of aluminium in Alzheimer's disease brain tissue: electron microprobe and ion microprobe studies, Neurosci Lett 123(1) (11 Feb. 1991), 61-64.
37. D.I. Claflin, M.B. Hennessy and S.J. Jensen, Sex-specific effects of corticosterone on hippocampally mediated learning in young rats, Physiol Behav 85(2) (2 Jun. 2005), 159-166.
38. L. Claudio, Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients, Acta Neuropathol (Berl) 91(1) (1996), 6-14.
39. M.T. Colomina, J.L. Roig, D.J. Sanchez and J.L. Domingo, Influence of age on aluminum-induced neurobehavioral effects and morphological changes in rat brain, Neurotoxicology 23(6) (Dec. 2002), 775-781.
40. 2+ modulatory action on GABA transport in brain cortex nerve terminals, J Inorg Biochem 97(1) (15 Sep. 2003), 132-142.
41. C. Craciun, A. Ardelean, A. Olteanu, A.C. Miu, R. Silasi-Mansat and L. Barbu-Tudoran, (2005) Effects of Aluminum Intoxication on Rat Liver, Histological and ultrastructural studies, Proceedings of the Ecological Society of America (ESA) Annual Meeting, Montreal, Canada.
42. D.R. Crapper McLachlan. Aluminum and Alzheimer's disease. Neurobiology of Aging 7(6) (November-December 1986), 525-532.
43. D.R. Crapper and A.J. Dalton, Alterations in short-term retention, conditioned avoidance response acquisition and motivation following aluminum induced neurofibrillary degeneration, Physiol Behav 10(5) (May 1973), 925-933.
44. D.R. Crapper, S.S. Krishnan and A.J. Dalton, Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration, Science 180(85) (4 May 1973), 511-513.
45. D.R. Crapper, S.S. Krishnan and S. Quittkat, Aluminium, neurofibrillary degeneration and Alzheimer's disease, Brain 99(1) (Mar. 1976), 67-80.
46. D.R. Crapper McLachlan, A.J. Dalton, T.P. Kruck, M.Y. Bell, W.L. Smith, W. Kalow and D.F. Andrews, Intramuscular desferrioxamine in patients with Alzheimer's disease, Lancet 337(8753) (1 Jun. 1991), 1304-1308.
47. J. Croom, I.L. Taylor and Y. Neuropeptide, peptide YY and aluminum in Alzheimer's disease: is there an etiological relationship? J Inorg Biochem 87(1-2) (Nov. 2001), 51-56.
48. R.R. Crichton, A. Florence and R.J. Ward, Aluminium and iron in the brain - prospects for chelation, Coordination Chemistry Reviews 228 (2002), 365-371.
49. G. De Stasio, D. Mercanti, M.T. Ciotti, D. Dunham, T.C. Droubay, B.P. Tonner, P. Perfetti and G. Margaritondo, Aluminium in rat cerebellar primary cultures: glial cells and GABAergic neurones, Neuroreport 5(15) (3 Oct. 1994), 1973-1976.
50. R. Deloncle, F. Huguet, P. Babin, B. Fernandez, N. Quellard and O. Guillard, Chronic administration of aluminium L-glutamate in young mature rats: effects on iron levels and lipid peroxidation in selected brain areas, Toxicol Lett 104(1-2) (11 Jan. 1999), 65-73.
51. R. Deloncle, F. Huguet, B. Fernandez, N. Quellard, P. Babin and O. Guillard, Ultrastructural study of rat hippocampus after chronic administration of aluminum L-glutamate: an acceleration of the aging process, Exp Gerontol 36(2) (Feb. 2001), 231-244.
52. D.A. Dewitt, J.A. Hurd, N. Fox, B.E. Townsend, K.J. Griffioen, O. Ghribi and J. Savory, Peri-nuclear clustering of mitochondria is triggered during aluminum maltolate induced apoptosis, J Alzheimers Dis 9(2) (Jul. 2006), 195-205.
53. R. Doll, Review: Alzheimer's disease and environmental aluminium, Age Ageing 22(2) (Mar. 1993), 138-153.
54. U. Döllken, U. Ueber die Wirkung des Aluminium mit besondrer Berucksichtigung der durch das aluminium verursachten Lasionen im Zentralnerven. system, Naunyn Schmiedebergs Arch Exp Path Pharmac 40 (1897), 58-120.
55. J.L. Domingo, Aluminum and other metals in Alzheimer's disease: A review of potential therapy with chelating agents, J Alzheimers Dis this issue.
56. C. Exley, A molecular mechanism of aluminium-induced Alzheimer's disease? J Inorg Biochem 76(2) (30 Aug. 1999), 133-140.
57. C. Exley, The pro-oxidant activity of aluminum, Free Radic Biol Med 36(3) (1 Feb. 2004), 380-387.
58. C. Exley, The aluminium-amyloid cascade hypothesis and Alzheimer's disease, Subcell Biochem 38 (2005), 225-234.
59. C. Exley, Aluminium and iron, but neither copper nor zinc, are key to the precipitation of β-sheets of Aβ42 in senile plaque cores in Alzheimer's disease, J Alzheimers Dis, this issue.
60. C. Exley and M.M. Esiri, Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK, J Neurol Neurosurg Psychiatry 77(7) (Jul. 2006), 877-879.
61. C. Exley, O. Korchazhkina, D. Job, S. Strekopytov, A. Polwart and P. Crome, Non-invasive therapy to reduce the body burden of aluminium in Alzheimer's disease, J Alzheimer's Dis 10(1) (2006), in press.
62. G.D. Fasman, Aluminum and Alzheimer's disease: model studies, Coord Chem Rev 149 (1996), 125-165.
63. G.D. Fasman and C.D. Moore, The solubilization of model Alzheimer tangles: reversing the beta-sheet conformation induced by aluminum with silicates, Proc Natl Acad Sci USA 91(23) (8 Nov. 1994), 11232-11235.
64. S.J. Fatemi, F.H. Kadir and G.R. Moore, Aluminium transport in blood serum. Binding of aluminium by human transferrin in the presence of human albumin and citrate, Biochem J 280(Pt 2) (1 Dec. 1991), 527-532.
65. T.P. Flaten, Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water, Brain Res Bull 55(2) (15 May 2001), 187-196.
66. T.P. Flaten, A.C. Alfrey, J.D. Birchall, J. Savory and R.A. Yokel, Status and future concerns of clinical and environmental aluminum toxicology, J Toxicol Environ Health 48(6) (30 Aug. 1996), 527-541.
67. J.A. Flendrig, H. Kruis and H.A. Das, Aluminum and dialysis dementia, Lancet 1(7971) (5 Jun. 1976), 1235.
68. S.J. Flora, A. Mehta, K. Satsangi, G.M. Kannan and M. Gupta, Aluminum-induced oxidative stress in rat brain: response to combined administration of citric acid and HEDTA, Comp Biochem Physiol C Toxicol Pharmacol 134(3) (Mar. 2003), 319-328.
69. A.L. Florence, A. Gauthie, C. Ponsar, P. Van den Bosch de Aguilar and R.R. Crichton, An experimental animal model of aluminium overload, Neurodegeneration 3(4) (Dec. 1994), 315-323.
70. J.F. Foncin, Alzheimer's disease and aluminium, Nature 326 (1987), 136.
71. W.F. Forbes, L.M. Hayward and N. Agwani, Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA) I. Results from a preliminary investigation, Can J Aging 11 (1992), 269-280.
72. W.F. Forbes, S. Lessard and J.F. Gentleman, Geochemical risk factors for mental functioning, based on the Ontario Longitudinal study of Aging (LSA) V. Comparisons of the results, relevant to aluminum water concentrations, obtained from the LSA and from death certificates mentioning dementia, Can J Aging 14 (1995), 642-656.
73. E. Gauthier, I. Fortier, F. Courchesne, P. Pepin, J. Mortimer and D. Gauvreau, Aluminum forms in drinking water and risk of Alzheimer's disease, Environ Res 84(3) (Nov. 2000), 234-246.
74. B. Ghetti, Induction of neurofibrillary degeneration following treatment with maytansine in vivo, Brain Res 163(1) (9 Mar. 1979), 9-19.
75. B. Ghetti and P. Gambetti, Comparative immunocytochemical characterization of neurofibrillary tangles in experimental maytansine and aluminum encephalopathies, Brain Res 276(2) (16 Oct. 1983), 388-393.
76. O. Ghribi, M.M. Herman, M.S. Forbes, D.A. DeWitt and J. Savory, GDNF protects against aluminum-induced apoptosis in rabbits by upregulating Bcl-2 and Bcl-XL and inhibiting mitochondrial Bax translocation, Neurobiol Dis 8(5) (Oct. 2001), 764-773.
77. O. Ghribi, D.A. DeWitt, M.S. Forbes, M.M. Herman and J. Savory, Co-involvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome c, Bcl-2 and Bax in the hippocampus of aluminum-treated rabbits, Brain Res 903(1-2) (8 Jun. 2001), 66-73.
78. O. Ghribi, M.M. Herman and J. Savory, The endoplasmic reticulum is the main site for caspase-3 activation following aluminum-induced neurotoxicity in rabbit hippocampus, Neurosci Lett 324(3) (24 May 2002), 217-221.
79. M.R. Gilbert, B.L. Harding, P.N. Hoffman, J.W. Griffin, D.L. Price and J.C. Troncoso, Aluminum-induced neurofilamentous changes in cultured rat dorsal root ganglia explants. J Neurosci 12(5) (May 1992), 1763-1771.
80. S. Gillette-Guyonnet, S. Andrieu, F. Nourhashemi, V. de La Gueronniere, H. Grandjean and B. Vellas, Cognitive impairment and composition of drinking water in women: findings of the EPIDOS Study, Am J Clin Nutr 81(4) (Apr. 2005), 897-902.
81. A. Gnjec, J.A. Fonte, C. Atwood and R.N. Martins, Transition metal chelator therapy-a potential treatment for Alzheimer's disease? Front Biosci 7 (1 Apr. 2002), d1016-d1023.
82. J. Goldstein, D.E. Newbury, D.C. Joy, C.E. Lyman, P. Echlin, E. Lifshin, L.C. Sawyer and J.R. Michael, Scanning Electron Microscopy and X-ray Microanalysis, Springer, New York, 2003.
83. M.S. Golub, B. Han, C.L. Keen, M.E. Gershwin and R.P. Tarara, Behavioral performance of Swiss Webster mice exposed to excess dietary aluminum during development or during development and as adults, Toxicol Appl Pharmacol 133(1) (Jul. 1995), 64-72.
84. M.S. Golub, S.L. Germann, B. Han and C.L. Keen, Lifelong feeding of a high aluminum diet to mice, Toxicology 150(1-3) (7 Sep. 2000), 107-117.
85. M.S. Golub and R.P. Tarara, Morphometric studies of myelination in the spinal cord of mice exposed developmentally to aluminum, Neurotoxicology 20(6) (Dec. 1999) 953-959.
86. M. Gomez, D.J. Sanchez, J.M. Llobet, J. Corbella and J.L. Domingo, The effect of age on aluminum retention in rats, Toxicology 116(1-3) (15 Jan. 1997), 1-8.
87. M. Gomez, D.J. Sanchez, J.M. Llobet, J. Corbella and J.L. Domingo, Concentrations of some essential elements in the brain of aluminum-exposed rats in relation to the age of exposure, Arch Gerontol Geriatr 24(3) (May-Jun 1997), 287-294.
88. P.F. Good, D.P. Perl, L.M. Bierer and J. Schmeidler, Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study, Ann Neurol 31(3) (Mar. 1992), 286-292.
89. P.F. Good and D.P. Perl, Aluminium in Alzheimer's? Nature 362(6419) (1 Apr. 1993), 418.
90. T. Gotow, Neurofilaments in health and disease, Med Electron Microsc 33(4) (2000), 173-199.
91. W.B. Grant, A. Campbell, R.F. Itzhaki and J. Savory, The significance of environmental factors in the etiology of Alzheimer's disease, J Alzheimers Dis 4(3) (Jun. 2002), 179-189.
92. V.B. Gupta, S. Anitha, M.L. Hegde, L. Zecca, R.M. Garruto, R. Ravid, S.K. Shankar, R. Stein, P. Shanmugavelu and K.S. Jagannatha Rao, Aluminium in Alzheimer's disease: are we still at a crossroad? Cell Mol Life Sci 62(2) (Jan. 2005), 143-158.
93. P. Hantson, P. Mahieu, M. Gersdorff, C.J. Sindic and R. Lauwerys, Encephalopathy with seizures after use of aluminium-containing bone cement, Lancet 344(8937) (10 Dec. 1994), 1647.
94. J. Hardy and D.J. Selkoe, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science 297(5580) (19 Jul. 2002), 353-356.
95. C. Hermenegildo, R. Saez, C. Minoia, L. Manzo and V. Felipo, Chronic exposure to aluminium impairs the glutamatenitric oxide-cyclic GMP pathway in the rat in vivo, Neurochem Int 34(3) (Mar. 1999), 245-253.
96. T.J. Hoeppner and F. Morrell, Control of scar formation in experimentally induced epilepsy, Exp Neurol 94(3) (Dec. 1986), 519-536.
97. E. House, J. Collingwood, A. Khan, O. Korchazkina, G. Berthon and C. Exley Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease, J Alzheimers Dis 6(3) (Jun. 2004), 291-301.
98. Y. Huang, M.M. Herman, J. Liu, C.D. Katsetos, M.R. Wills and J. Savory, Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquitin-protein conjugates, Brain Res 771(2) (17 Oct. 1997), 213-220.
99. T.C. Iancu, D.P. Perl, I. Sternlieb, A. Lerner, E. Leshinsky, E.H. Kolodny, A. Hsu and P.F. Good, The application of laser microprobe mass analysis to the study of biological material, Biometals 9(1) (Jan. 1996), 57-65.
100. P. Imray, M.R. Moore, P.W. Callan and L.W. Summary, in: Aluminium: Report of an international meeting 20-21 April 1995, P. Imray, M.R. Moore, P.W. Callan and W. Lock, eds, Brisbane (p. 4). National Environmental Health Forum Monographs, Metal Series No. 1, 1998.
101. R.W. Jacobs, T. Duong, R.E. Jones, G.A. Trapp and A.B. Scheibel, A reexamination of aluminum in Alzheimer's disease: analysis by energy dispersive X-ray microprobe and flameless atomic absorption spectrophotometry, Can J Neurol Sci 16(4 Suppl) (Nov. 1989), 498-503.
102. E.T. Jansson, Alzheimer disease is substantially preventable in the United States - review of risk factors, therapy, and the prospects for an expert software system, Med Hypotheses 64(5) (2005), 960-967.
103. D. Julka and K.D. Gill, Altered calcium homeostasis: a possible mechanisms of aluminium-induced neurotoxicity, Biochim Biophys Acta 1315(1) (17 Jan. 1996), 47-54.
104. P. Kasa, P. Szerdahelyi and H.M. Wisniewski, Lack of topographical relationship between sites of aluminum deposition and senile plaques in the Alzheimer's disease brain, Acta Neuropathol (Berl) 90(5) (1995), 526-531.
105. A. Kaur, K. Joshi, R.W. Minz and K.D. Gill, Neurofilament phosphorylation and disruption: a possible mechanism of chronic aluminium toxicity in Wistar rats, Toxicology 219(1-3) (15 Feb 2006), 1-10.
106. M. Kawahara, Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases, J Alzheimers Dis 8(2) (Nov. 2005), 171-182;
107. M. Kawahara, M. Kato and Y. Kuroda, Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein, Brain Res Bull 55(2) (15 May 2001), 211-217.
108. M. Kidd, Paired helical filaments in electron microscopy of Alzheimer's disease, Nature 197 (12 Jan. 1963), 192-193.
109. M. Kidd, The history of the paired helical filaments, J Alzheimers Dis 9(3 Suppl) (Aug. 2006), 71-75.
110. K.H. Kilburn, Does exposure to fine aluminium dust affect the brain? Lancet 354(9190) (6 Nov. 1999), 1575-1577.
111. M.S. Kim and L.S. Clesceri, Aluminum exposure: a study of an effect on cellular growth rate, Sci Total Environ 278(1-3) (20 Oct. 2001), 127-135.
112. I. Klatzo and H. Wisniewski, E. Streicher, experimental production of neurofibrillary degeneration: I. Light microscopic observations, J Neuropathol Exp Neurol 24 (Apr. 1965), 187-199.
113. T. Kohila, E. Parkkonen and H. Tahti, Evaluation of the effects of aluminium, ethanol and their combination on rat brain synaptosomal integral proteins in vitro and after 90-day oral exposure, Arch Toxicol 78(5) (May 2004), 276-282.
114. L.M. Kopeloff, S.E. Barrera and N. Kopeloff, Recurrent convulsive seizures in animals produced by immunologic and chemical means, Am J Psychiatr 98 (1942), 881-886.
115. K.S. Kosik, W.G. Bradley, P.F. Good, C.G. Rasool and D.J. Selkoe, Cholinergic function in lumbar aluminum myelopathy, J Neuropathol Exp Neurol 42(4) (Jul. 1983), 365-375.
116. K.S. Kosik, A.H. McCluskey, F.X. Walsh and D.J. Selkoe, Axonal transport of cytoskeletal proteins in aluminum toxicity. Aluminum toxicity and axonal transport, Neurochem Pathol 3(2) (1985 Summer), 99-108.
117. N.W. Kowall, W.W. Pendlebury, J.B. Kessler, D.P. Perl and M.F. Beal, Aluminum-induced neurofibrillary degeneration affects a subset of neurons in rabbit cerebral cortex, basal forebrain and upper brainstem, Neuroscience 29(2) (1989), 329-337.
118. S.S. Krishnan, D.R. McLachlan, B. Krishnan, S.S. Fenton and J.E. Harrison, Aluminum toxicity to the brain, Sci Total Environ 71(1) (Apr. 1988), 59-64.
119. S. Kumar, Biphasic effect of aluminium on cholinergic enzyme of rat brain, Neurosci Lett 248(2) (29 May 1998), 121-123.
120. S. Kumar, Aluminium-induced changes in the rat brain serotonin system, Food Chem Toxicol 40(12) (Dec. 2002), 1875-1880.
121. J.P. Landsberg, B. McDonald and F. Watt, Absence of aluminium in neuritic plaque cores in Alzheimer's disease, Nature 360(6399) (5 Nov. 1992), 65-68.
122. J. Landsberg, B. McDonald, G. Grime and F. Watt, Microanalysis of senile plaques using nuclear microscopy, J Geriatr Psychiatry Neurol 6(2) (Apr-Jun 1993), 97-104.
123. S. Lesne, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, M. Gallagher and K.H. Ashe, A specific amyloid-beta protein assembly in the brain impairs memory, Nature 440(7082) (16 Mar. 2006), 352-357.
124. G. Liu, M.R. Garrett, P. Men, X. Zhu, G. Perry and M.A. Smith, Nanoparticle and other metal chelation therapeutics in Alzheimer disease, Biochim Biophys Acta 1741(3) (25 Sep. 2005), 246-252.
125. B.H. Liwnicz, K. Kristensson, H.M. Wisniewski, M.L. Shelanski and R.D. Terry, Observations on axoplasmic transport in rabbits with aluminum-induced neurofibrillary tangles, Brain Res 80(3) (22 Nov. 1974), 413-420.
126. M.A. Lovell, W.D. Ehmann and W.R. Markesbery, Laser microprobe analysis of brain aluminum in Alzheimer's disease, Ann Neurol 33(1) (Jan. 1993), 36-42.
127. W.J. Lukiw, B. Krishnan, L. Wong, T.P. Kruck, C. Bergeron and D.R. Crapper McLachlan, Nuclear compartmentalization of aluminum in Alzheimer's disease (AD), Neurobiol Aging 13(1) ( Jan-Feb 1992), 115-121.
128. T.L. Macdonald, W.G. Humphreys and R.B. Martin, Promotion of tubulin assembly by aluminum ion in vitro, Science 236(4798) (10 Apr. 1987), 183-186.
129. J. Makjanic, B. McDonald, C.P. Li-Hsian Chen and F. Watt, Absence of aluminium in neurofibrillary tangles in Alzheimer's disease, Neurosci Lett 240(3) (16 Jan. 1998), 123-126.
130. W.R. Markesbery, W.D. Ehmann, T.I. Hossain, M. Alauddin and D.T. Goodin, Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging, Ann Neurol 10(6) (Dec. 1981), 511-516.
131. C.N. Martyn, D.J. Barker, C. Osmond, E.C. Harris, J.A. Edwardson and R.F. Lacey, Geographical relation between Alzheimer's disease and aluminum in drinking water, Lancet 1(8629) (14 Jan. 1989), 59-62.
132. C.N. Martyn, D.N. Coggon, H. Inskip, R.F. Lacey and W.F. Young, Aluminum concentrations in drinking water and risk of Alzheimer's disease, Epidemiology 8(3) (May 1997), 281-286.
133. J.R. McDermott, A.I. Smith, K. Iqbal and H.M. Wisniewski, Aluminium and Alzheimer's disease, Lancet 2(8040) (1 Oct. 1977), 710-711.
134. J.R. McDermott, A.I. Smith, M.K. Ward, I.S. Parkinson and D.N. Kerr, Brain-aluminium concentration in dialysis encephalopathy, Lancet 1(8070) (29 Apr. 1978), 901-904.
135. D.R. McLachlan, C. Bergeron, J.E. Smith, D. Boomer and S.L. Rifat, Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories, Neurology 46(2) (Feb. 1996), 401-405.
136. M. Mesulam, The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem 11(1) (Jan-Feb 2004), 43-49.
137. A.C. Miu, C.E. Andreescu, R. Vasiu and A.I. Olteanu, A behavioral and histological study of the effects of long-term exposure of adult rats to aluminum, Int J Neurosci 113(9) (Sep. 2003), 1197-211.
138. A.C. Miu, R.I. Medrea, C.E. Andreescu, C.I. Stancu, N. Vlasie and A.I. Olteanu, Impaired recognition memory and emotional reactivity associated to loss of cortical integrity in rats after chronic exposure to aluminium, Cognition, Brain, Behavior 7 (2003), 219-234.
139. A.C. Miu, A.I. Olteanu and M. Miclea, A behavioral and ultrastructural dissection of the interference of aluminum with aging, J Alzheimers Dis 6(3) (Jun. 2004), 315-328.
140. P.B. Moore, J.P. Day, G.A. Taylor, I.N. Ferrier, L.K. Fi-field and J.A. Edwardson, Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry, Dement Geriatr Cogn Disord 11(2) (Mar-Apr 2000), 66-69.
141. T. Morie, M. Iwamoto, N. Harada, S. Masumoto, M. Yamada and Y. Kusunose, Urinary excretion of aluminium: effects of aging and diurnal variation, Arch Gerontol Geriatr 22(3) (May-Jun 1996), 287-295.
142. A.A. Moshtaghie, S. Rahimi and M. Messripour, Changes in catecholamine levels of cerebellum, mid-brain and brain-cortex in aluminium intoxified rats, Indian J Pharmacol 28 (1996), 244-248.
143. A.A. Moshtaghie, S. Rahimi and M. Messripour, Aluminium administration on acetylcholinesterase activity of different regions of rat brain, Med J IAS 12(4) (1999), 105-108.
144. D. Munoz-Garcia, W.W. Pendlebury, J.B. Kessler and D.P. Perl, An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles, Acta Neuropathol (Berl) 70(3-4) (1986), 243-248.
145. P. Nayak and A.K. Chatterjee, Effects of aluminium exposure on brain glutamate and GABA systems: an experimental study in rats, Food Chem Toxicol 39(12) (Dec. 2001), 1285-1289.
146. P. Nayak and A.K. Chatterjee, Response of regional brain glutamate transaminases of rat to aluminum in protein malnutrition, BMC Neurosci 3 (28 Aug. 2002), 12.
147. P. Nayak and A.K. Chatterjee, Dietary protein restriction causes modification in aluminum-induced alteration in glutamate and GABA system of rat brain, BMC Neurosci 4 (25 Feb. 2003), 4.
148. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease, Am J Kidney Dis 42(4 Suppl 3) (Oct. 2003), S1-S201.
149. L.C. Neri and D. Hewitt, Aluminium, Alzheimer's disease, and drinking water, Lancet 338(8763) (10 Aug. 1991), 390.
150. J.D. Pandya, K.R. Dave and S.S. Katyare, Effect of long-term aluminum feeding on lipid/phospholipid profiles of rat brain myelin, Lipids Health Dis 3 (22 Jun. 2004), 13.
151. D.P. Perl, The aluminum hypothesis of Alzheimer's disease: A personal view based on microprobe analysis Neurobiology of Aging, Volume 7, Issue 6, November-December 1986, 550-552.
152. D.P. Perl, The association of aluminium and neurodegenerative disease (1980 to 2005) - Personal recollections and future perspectives. Proceedings of the Sixth Keele Meeting on Aluminium, Busaco, Portugal.
153. D.P. Perl and A.R. Brody, Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons, Science 208(4441) (18 Apr. 1980), 297-299.
154. D.P. Perl and P.F. Good, Aluminum, environment and Alzheimer's disease: active role or passive bystander? Neurobiology of Aging 11(1) (January-February 1990), 83.
155. D.P. Perl and P.F. Good, Aluminium and the neurofibrillary tangle: results of tissue microprobe studies, Ciba Found Symp 169 (1992), 217-227.
156. D.P. Perl and P.F. Good, Does aluminium play a role in neurodegeneration? An update. In NDPriest, TVO'Donnell, Managing Health in the Aluminium Industry (pp. 260-262). Middlesex University Press, London, 1998.
157. P.D. Perl, C.D. Gadjusek, R.M. Garruto, R.T. Yanagihara, Jr. and C.J. Gibbs, Intraneuronal aluminium accumulation in amyotrophic lateral sclerosis and parkinsonism dementia, Science 217 (1982), 1053-1055.
158. D.P. Perl and S. Moalem, Aluminum and Alzheimer's disease, a personal perspective after 25 years, Journal of Alzheimer's Disease 9 (2006), 291-300.
159. B. Platt, Experimental approaches to assess metallotoxicity and ageing in models of Alzheimer's disease, J Alzheimer's Dis, this issue.
160. B. Platt, G. Fiddler, G. Riedel and Z. Henderson, Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence, Brain Res Bull 55(2) (15 May 2001), 257-267.
161. D. Pratico, K. Uryu, S. Sung, S. Tang, J.Q. Trojanowski and V.M. Lee, Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice, FASEB J 16(9) (Jul. 2002), 1138-1140.
162. N.D. Priest, R.J. Talbot, D. Newton, J.P. Day, S.J. King and L.K. Fifield, Uptake by man of aluminium in a public water supply, Hum Exp Toxicol 17(6) (Jun. 1998), 296-301.
163. A. Rabe, M.H. Lee, J. Shek and H.M.Wisniewski, Learning deficit in immature rabbits with aluminum-induced neurofibrillary changes, Exp Neurol 76(2) (May 1982), 441-446.
164. M.T. Rajan, K.S. Jagannatha Rao, B.M. Mamatha, R.V. Rao, P. Shanmugavelu, R.B. Menon and M.V. Pavithran, Quantification of trace elements in normal human brain by inductively coupled plasma atomic emission spectrometry, J Neurol Sci 146(2) (10 Mar. 1997), 153-166.
165. J.K. Rao, C.D. Katsetos, M.M. Herman and J. Savory, Experimental aluminum encephalomyelopathy. Relationship to human neurodegenerative disease, Clin Lab Med 18(4) (Dec. 1998), 687-698.
166. E. Reusche, Argyrophilic inclusions distinct from Alzheimer neurofibrillary changes in one case of dialysis-associated encephalopathy, Acta Neuropathol (Berl) 94(6) (Dec. 1997), 612-616.
167. E. Reusche, V. Koch, B. Lindner, A.P. Harrison and H.J. Friedrich, Alzheimer morphology is not increased in dialysis-associated encephalopathy and long-term hemodialysis, Acta Neuropathol (Berl) 101(3) (Mar. 2001), 211-216.
168. E. Reusche, P. Pilz, G. Oberascher, B. Lindner, R. Egensperger, K. Gloeckner, E. Trinka and B. Iglseder, Subacute fatal aluminum encephalopathy after reconstructive otoneurosurgery: a case report, Hum Pathol 32(10) (Oct. 2001), 1136-1140.
169. E. Reusche and U. Seydel, Dialysis-associated encephalopathy: light and electron microscopic morphology and topography with evidence of aluminum by laser microprobe mass analysis, Acta Neuropathol (Berl) 86(3) (1993), 249-258.
170. S.R. Robinson and G.M. Bishop, Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease, Neurobiol Aging 23(6) (Nov-Dec 2002), 1051-1072.
171. M.A. Rogers and D.G. Simon, A preliminary study of dietary aluminium intake and risk of Alzheimer's disease, Age Ageing 28(2) (Mar. 1999), 205-209.
172. V. Rondeau, D. Commenges, H. Jacqmin-Gadda and J.F. Dartigues, Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study, Am J Epidemiol 152(1) (1 Jul. 2000), 59-66.
173. Y. Sato, S.U. Kim and B. Ghetti, Induction of neurofibrillary tangles in cultured mouse neurons by maytanprine, J Neurol Sci 68(2-3) (May 1985), 191-203.
174. J. Savory, C. Exley, W.F. Forbes, Y. Huang, J.G. Joshi, T. Kruck, D.R. McLachlan and I. Wakayama, Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? J Toxicol Environ Health 48(6) (30 Aug. 1996), 615-635.
175. J. Savory, O. Ghribi and M.M. Herman, Is amyloid betapeptide neurotoxic
176. J. Savory, Y. Huang, M.M. Herman, M.R. Reyes and M.R. Wills, Tau immunoreactivity associated with aluminum maltolate-induced neurofibrillary degeneration in rabbits, Brain Res 669(2) (16 Jan. 1995), 325-329.
177. J. Savory, Y. Huang, M.M. Herman and M.R. Wills, Quantitative image analysis of temporal changes in tau and neurofilament proteins during the course of acute experimental neurofibrillary degeneration; non-phosphorylated epitopes precede phosphorylation, Brain Res 707(2) (29 Jan. 1996), 272-281.
178. J. Savory, Y. Huang, M.R. Wills and M.M. Herman, Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease, Neurotoxicology 19(2) (Apr. 1998), 209-214.
179. J. Savory, O. Ghribi, M.S. Forbes and M.M. Herman, Aluminium and neuronal cell injury: inter-relationships between neurofilamentous arrays and apoptosis, J Inorg Biochem 87(1-2) (Nov. 2001), 15-19.
180. J. Savory, M.M. Herman and O. Ghribi, Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain, J Inorg Biochem 97(1) (15 Sep. 2003), 151-154.
181. J. Savory and M.M. Herman, Othman Ghribi. Mechanisms of aluminum-induced neurodegeneration in animals: implications for Alzheimer's disease, J Alzheimer's Dis, this issue.
182. N.R. Shah, O.R. Oberkircher and J.S. Lobel, Aluminum-induced microcytosis in a child with moderate renal insufficiency, Am J Pediatr Hematol Oncol 12(1) (Spring 1990), 77-79.
183. T.B. Shea, M.L. Beermann and F.S. Wang, Relative susceptibility of cytoskeleton-associated and soluble neurofilament subunits to aluminum exposure in intact cells. A possible mechanism for reduction of neurofilament axonal transport during aluminum neurotoxicity, Mol Chem Neuropathol 24(2-3) (Feb-Apr 1995), 203-219.
184. V.S. Silva, J.M. Cordeiro, M.J. Matos, C.R. Oliveira and P.P. Goncalves, Aluminum accumulation and membrane fluidity alteration in synaptosomes isolated from rat brain cortex following aluminum ingestion: effect of cholesterol, Neurosci Res 44(2) (Oct. 2002), 181-193.
185. B. Sjogren, Biological estimates of aluminium exposure and its effects on the nervous system in occupationally exposed workers, in: Managing Health in the Aluminium Industry, N.D. Priest and T.V. O'Donnell, eds, Middlesex University Press, London, 1998, pp. 274-277.
186. B. Solomon, R. Koppel and J. Jossiphov, Immunostaining of calmodulin and aluminium in Alzheimer's disease-affected brains, Brain Res Bull 55(2) (15 May 2001), 253-256.
187. P.R. Solomon, T.M. Pingree, D. Baldwin, D. Koota, D.P. Perl and W.W. Pendlebury, Disrupted retention of the classically conditioned nictitating membrane response in rabbits with aluminum-induced neurofibrillary degeneration, Neurotoxicology 9(2) (Summer 1988), 209-221.
188. E. Sreekumaran, T. Ramakrishna, T.R. Madhav, D. Anandh, B.M. Prabhu, S. Sulekha, P.N. Bindu and T.R. Raju, Loss of dendritic connectivity in CA1, CA2, and CA3 neurons in hippocampus in rat under aluminum toxicity: antidotal effect of pyridoxine, Brain Res Bull 59(6) (15 Feb. 2003), 421-427.
189. A. Stacchiotti, L.F. Rodella, F. Ricci, R. Rezzani, A. Lavazza and R. Bianchi, Stress proteins expression in rat kidney and liver chronically exposed to aluminium sulphate, Histol Histopathol 21(2) (Feb. 2006), 131-40.
190. A.J. Stern, D.P. Perl, D. Munoz-Garcia, P.F. Good, C. Abraham and D.J. Selkoe, Investigation of silicon and aluminum content in isolated plaque cores by laser microprobe mass analysis (LAMMA), J Neuropathol Exp Neurol 45 (1986), 361.
191. C. Struys-Ponsar, A. Florence, A. Gauthier, R.R. Crichton and P. van den Bosch de Aguilar, Ultrastructural changes in brain parenchyma during normal aging and in animal models of aging, J Neural Transm 44(Suppl) (1994), 111-132.
192. C. Struys-Ponsar, A. Kerkhofs, A. Gauthier, M. Soffie and P. van den Bosch de Aguilar, Effects of aluminum exposure on behavioral parameters in the rat, Pharmacol Biochem Behav 56(4) (Apr. 1997), 643-648.
193. C. Struys-Ponsar, O. Guillard and P. van den Bosch de Aguilar, Effects of aluminum exposure on glutamate metabolism: a possible explanation for its toxicity, Exp Neurol 163(1) (May 2000), 157-164.
194. J.A. Sturman, H.M. Wisniewski and J.W. Shek, High affinity uptake of GABA and glycine by rabbits with aluminum-induced neurofibrillary changes, Neurochem Res 8(9) (Sep. 1983), 1097-109.
195. M.B. Suarez-Fernandez, A.B. Soldado, A. Sanz-Medel, J.A. Vega, A. Novelli and M.T. Fernandez-Sanchez, Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death, Brain Res 835(2) (24 Jul. 1999), 125-136.
196. C.V. Swegert, K.R. Dave and S.S. Katyare, Effect of aluminium-induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria, Mech Ageing Dev 112(1) (7 Dec. 1999), 27-42.
197. R.D. Terry, Henry M. Wisniewski - Fond memories, J Alzheimers Dis 3(1) (2001), 5.
198. R.D. Terry and C. Pena, (1965) Experimental production of neurofibrillary degeneration: II. Electron microscopy, phosphatase histochemistry and electron probe analysis, J Neuropathol Exp Neurol 24 (Apr. 1965), 187-199.
199. S. Tokutake, Accumulation of aluminum and silicon in lipofuscin granules suggests retardation of blood-brain barrier function by aging, Ann N Y Acad Sci 826 (26 Sep. 1997), 510-512.
200. S. Tokutake, H. Nagase, S. Morisaki and S. Oyanagi, Aluminium detected in senile plaques and neurofibrillary tangles is contained in lipofuscin granules with silicon, probably as aluminosilicate, Neurosci Lett 185(2) (9 Feb. 1995), 99-102.
201. S. Tokutake and S. Oyanagi, Accumulation of aluminium and silicon in lipofuscin granules, Gerontology 41(Suppl 2) (1995), 131-44.
202. J.C. Troncoso, P.N. Hoffman, J.W. Griffin, K.M. Hess-Kozlow and D.L. Price, Aluminum intoxication: a disorder of neurofilament transport in motor neurons, Brain Res 342(1) (2 Sep. 1985), 172-175.
203. J.C. Troncoso, D.L. Price, J.W. Griffin and I.M. Parhad, Neurofibrillary axonal pathology in aluminum intoxication, Ann Neurol 12(3) (Sep. 1982), 278-283.
204. F.P. Underhil, F.I. Peterman and A. Sperandeo, STUDIES IN THE METABOLISM OF ALUMINIUM: VIII. A Note on the Toxic Effects Produced by Subcutaneous Injection of Aluminium Salts, Am J Physiol 90 (1929), 76-82.
205. G.B. van der Voet, M.F. van Ginkel and F.A. de Wolff, Intestinal absorption of aluminum in rats: stimulation by citric acid and inhibition by dinitrophenol, Toxicol Appl Pharmacol 99(1) (1 Jun. 1989), 90-97.
206. G.F. Van Landeghem, C. Sikstrom, L.E. Beckman, R. Adolfsson and L. Beckman, Transferrin C2, metal binding and Alzheimer's disease, Neuroreport 9(2) (26 Jan. 1998), 177-179.
207. S.J. van Rensburg, M.E. Carstens, F.C. Potocnik, A.K. Aucamp and J.J. Taljaard, Increased frequency of the transferrin C2 subtype in Alzheimer's disease, Neuroreport 4(11) (10 Sep. 1993), 1269-1271.
208. J.A. Varner, K.F. Jensen, W. Horvath and R.L. Isaacson, Chronic administration of aluminum-fluoride or sodium-fluoride to rats in drinking water: alterations in neuronal and cerebrovascular integrity, Brain Res 784(1-2) (16 Feb. 1998), 284-298.
209. S.V. Verstraeten, M.S. Golub, C.L. Keen and P.I. Oteiza, Myelin is a preferential target of aluminum-mediated oxidative damage, Arch Biochem Biophys 344(2) (15 Aug. 1997), 289-294.
210. J. Walton, Absorption of aluminium and its effects on brain cells, in: Aluminium: Report of an International Meeting 20-21 April 1995, P. Imray, M.R. Moore, P.W. Callan and W. Lock, eds, Brisbane, National Environmental Health Forum Monographs, Metal Series No. 1, 1998, pp. 22-34.
211. J.R. Walton, Aluminum in hippocampal neurons from humans with Alzheimer's disease, NeuroToxicology 27(3) (May 2006), 385-394.
212. M.Wang, D.Y. Ruan, J.T. Chen and Y.Z. Xu, Lack of effects of vitamin E on aluminium-induced deficit of synaptic plasticity in rat dentate gyrus in vivo, Food Chem Toxicol 40(4) (Apr. 2002), 471-478.
213. R.J. Ward, Y. Zhang and R.R. Crichton, Aluminium toxicity and iron homeostasis, J Inorg Biochem 87(1-2) (Nov. 2001), 9-14.
214. F. Watt, Nuclear microscope analysis in Alzheimer's and Parkinson's disease: A review, Cell Mol Biol (Noisy-legrand) 42(1) (Feb. 1996), 17-26.
215. J.R. Whitlock, A.J. Heynen, M.G. Shuler and M.F. Bear, Learning induces long-term potentiation in the hippocampus, Science 313(5790) (25 Aug. 2006), 1093-1097.
216. H.M. Wisniewski and G.Y. Wen, Aluminium and Alzheimer's disease, Ciba Found Symp 169 (1992), 142-154.
217. World Health Organization. Aluminium. Geneva, WHO, International Program on Chemical safety (Environmental Health Criteria 194), 1997.
218. H.M. Wisniewski and T.I. Lidsky, The role of aluminium in Alzheimer's disease, in: Managing Health in the Aluminium Industry, N.D. Priest and T.V. O'Donnell, eds, Middlesex University Press, London, 1998, pp. 263-273.
219. H.M. Wisniewski, R.C. Moretz and K. Iqbal, No evidence for aluminum in etiology and pathogenesis of Alzheimer's disease, Neurobiology of Aging 7(6) (November-December 1986), 532-535.
220. H.M. Wisniewski, J.W. Shek, S. Gruca and J.A. Sturman, Aluminum-induced neurofibrillary changes in axons and dendrites, Acta Neuropathol (Berl) 63(3) (1984), 190-197.
221. H.M. Wisniewski and J.A. Sturman, Neurotoxicity of aluminum, in: Aluminum and Health, H.J. Gitelman, ed., Marcel Dekker, New York, 1989, pp. 125-165.
222. H.M. Wisniewski, J.A. Sturman and J.W. Shek, Chronic model of neurofibrillary changes induced in mature rabbits by metallic aluminum, Neurobiol Aging 3(1) (Spring 1982), 11-22.
223. H.Wisniewski and R.D. Terry, Further studies on experimental neurofibrillary tangles, J Neuropathol Exp Neurol 27(1) (Jan. 1968), 149-150.
224. H.M. Wisniewski and G.Y. Wen, Aluminium and Alzheimer's disease, Ciba Found Symp 169 (1992), 142-154.
225. T. Wisniewski, M. Henry and M.D. Wisniewski, Ph.D, J Alzheimers Dis 3(1) (Feb. 2001), 7-22.
226. R.A. Yokel, Aluminum produces age related behavioral toxicity in the rabbit, Neurotoxicol Teratol 11(3) (May-Jun 1989), 237-242.
227. B.A. Yokel, The toxicology of aluminum in the brain: a review, Neurotoxicology 21(5) (Oct. 2000), 813-828.
228. S. Yumoto, H. Ohashi, H. Nagai, S. Kakimi, A. Ishikawa, K. Kobayashi, Y. Ogawa and K. Ishii, Aluminium toxicity in the rat liver and brain, Nuclear Instruments and Methods in Physics Research Section B 75(1-4), 188-190.
229. R.A. Yokel, Blood-Brain Barrier Flux of Aluminum, Manganese, Iron and Other Metals Suspected to Contribute to Metal-Induced Neurodegeneration, J Alzheimer's Dis this issue.
230. R.A. Yokel and J.P. O'Callaghan, An aluminum-induced increase in GFAP is attenuated by some chelators, Neurotoxicol Teratol 20(1) (Jan-Feb 1998), 55-60.
231. P. Zatta, T. Kiss, M. Suwalsky and G. Berthon, Aluminium (III) as a promoter of cellular oxidation, Coord Chem. Rev 228 (2002), 271-284.
232. P. Zatta, R. Lucchini, S.J. van Rensburg and A. Taylor, The role of metals in neurodegenerative processes: aluminum, manganese, and zinc, Brain Res Bull 62(1) (15 Nov. 2003), 15-28.
233. P. Zatta, P. Zambenedetti, E. Reusche, F. Stellmacher, A. Cester, P. Albanese, G. Meneghel and M. Nordio, A fatal case of aluminium encephalopathy in a patient with severe chronic renal failure not on dialysis, Nephrol Dial Transplant 19(11) (Nov. 2004), 2929-2931.
234. W. Zheng, Neurotoxicology of the brain barrier system: new implications, J Toxicol Clin Toxicol 39(7) (2001), 711-719.